江龍船艇(300589.SZ):海洋先進船艇智能製造項目陸地工程已於2022年底完工
格隆匯5月9日丨有投資者在投資者互動平台向江龍船艇(300589.SZ)提問,“請問貴司最大年產能有多少?”
江龍船艇回覆稱,公司海洋先進船艇智能製造項目陸地工程已於2022年底完工,陸地工程完工後可部分滿足船舶下水前的生產需求,目前公司該基地已部分投產。水下工程則按計劃推進,預計2024年初本項目建成並全部投入使用,本項目達到設計能力時,預計年產值可達9.1億元(不含税)。 目前公司產能大致分為中山一廠(中山原有生產基地)、中山二廠(海洋先進船艇智能製造項目)、珠海廠、澳龍廠。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.